Abstract | RATIONALE: PATIENT CONCERNS: A 77-year-old woman underwent angiography and cardiac catheterization, before descending aortic replacement surgery. She developed DIC in postprocedure week 2 with extensive, uncontrollable massive subcutaneous hemorrhage. DIAGNOSES: Her acute-phase DIC score was 7 points, and the risk of mortality within 30 days after surgery according to the JapanSCORE was estimated to be 33.6%. INTERVENTIONS: OUTCOMES: LESSONS: We report the use of rhTM as an effective, novel anticoagulant drug with anti-inflammatory activity for treating DIC with suppressed fibrinolysis, which is typically associated with sepsis. In patients with a high hemorrhagic diathesis, in whom preoperative control of DIC cannot be achieved with conventional anticoagulation and radical surgical repair cannot be performed, a combination of rhTM and endovascular therapy may be a powerful new treatment option.
|
Authors | Yoshinori Tanigawa, Yasutaka Yamada, Kimihide Nakamura, Tomoko Yamashita, Akira Nakagawachi, Yoshiro Sakaguchi |
Journal | Medicine
(Medicine (Baltimore))
Vol. 100
Issue 9
Pg. e25044
(Mar 05 2021)
ISSN: 1536-5964 [Electronic] United States |
PMID | 33655983
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. |
Chemical References |
- Recombinant Proteins
- Thrombomodulin
|
Topics |
- Aged
- Angiography
- Aortic Aneurysm, Thoracic
(diagnosis, etiology, surgery)
- Disseminated Intravascular Coagulation
(complications, drug therapy)
- Dose-Response Relationship, Drug
- Female
- Humans
- Injections, Intravenous
- Preoperative Care
(methods)
- Recombinant Proteins
(administration & dosage)
- Thrombomodulin
(administration & dosage)
- Vascular Surgical Procedures
|